These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7603219)

  • 1. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women.
    Proudler AJ; Ahmed AI; Crook D; Fogelman I; Rymer JM; Stevenson JC
    Lancet; 1995 Jul; 346(8967):89-90. PubMed ID: 7603219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal women.
    Proudler AJ; Cooper A; Whitehead M; Stevenson JC
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):30-5. PubMed ID: 12519409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women.
    Nogawa N; Sumino H; Ichikawa S; Kumakura H; Takayama Y; Nakamura T; Kanda T; Mizunuma H; Kurabayashi M
    Menopause; 2001; 8(3):210-5. PubMed ID: 11355044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy.
    Agrawal R; Prelevic G; Conway GS; Payne NN; Ginsburg J; Jacobs HS
    Fertil Steril; 2000 Jan; 73(1):56-60. PubMed ID: 10632412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy in postmenopausal women with essential hypertension increases circulating plasma levels of bradykinin.
    Sumino H; Ichikawa S; Kanda T; Sakamaki T; Nakamura T; Sato K; Kobayashi I; Nagai R
    Am J Hypertens; 1999 Oct; 12(10 Pt 1):1044-7. PubMed ID: 10560792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype.
    Sumino H; Ichikawa S; Ohyama Y; Nakamura T; Kanda T; Sakamoto H; Sakamaki T; Mizunuma H; Kurabayashi M
    Hypertens Res; 2003 Jan; 26(1):53-8. PubMed ID: 12661913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen replacement therapy in postmenopausal women augments reactive hyperemia in the forearm by reducing angiotensin converting enzyme activity.
    Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Sakashita T; Tsuda M; Ohama K
    Atherosclerosis; 2001 Oct; 158(2):391-7. PubMed ID: 11583718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement effects on endothelial function measured in the forearm resistance artery in normocholesterolemic and hypercholesterolemic postmenopausal women.
    Sanada M; Higashi Y; Nakagawa K; Tsuda M; Kodama I; Kimura M; Chayama K; Ohama K
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4634-41. PubMed ID: 12364448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.
    Georgiev DB; Manassiev NA
    Medscape Womens Health; 2002; 7(4):1. PubMed ID: 12466733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F; Terek MC; Karadadaş N; Bilgin O
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy does not affect the 24-hour heart rate variability in postmenopausal women: results of a randomized, placebo-controlled trial with two regimens.
    Fernandes EO; Moraes RS; Ferlin EL; Wender MC; Ribeiro JP
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S172-7. PubMed ID: 15683490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women.
    Miya Y; Sumino H; Ichikawa S; Nakamura T; Kanda T; Kumakura H; Takayama Y; Mizunuma H; Sakamaki T; Kurabayashi M
    Hypertens Res; 2002 Mar; 25(2):153-9. PubMed ID: 12047028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hormone replacement therapy on salivary flow rate, buffer effect and pH on perimenopausal and postmenopausal women.
    Laine M; Leimola-Virtanen R
    Arch Oral Biol; 1996 Jan; 41(1):91-6. PubMed ID: 8833596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G; Ozmen B; Erguder I
    Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ovariectomy and estrogen replacement on aorta angiotensin-converting enzyme activity in rats.
    Tanaka M; Nakaya S; Watanabe M; Kumai T; Tateishi T; Kobayashi S
    Jpn J Pharmacol; 1997 Apr; 73(4):361-3. PubMed ID: 9165375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women.
    Schunkert H; Danser AH; Hense HW; Derkx FH; Kürzinger S; Riegger GA
    Circulation; 1997 Jan; 95(1):39-45. PubMed ID: 8994414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).
    Simon JA; Lin F; Vittinghoff E; Bittner V;
    Ann Epidemiol; 2006 Feb; 16(2):138-45. PubMed ID: 16039873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.